Kite Pharma, Inc. Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | M | 1.35 | 8,100 | 10,935 | 327,294 | |
| Jan 29 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 53.12 | 100 | 5,312 | 94,007 | 94.1 K to 94 K (-0.11 %) |
| Jan 29 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 52.91 | 2,800 | 148,148 | 94,107 | 96.9 K to 94.1 K (-2.89 %) |
| Jan 29 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 51.34 | 2,700 | 138,618 | 96,907 | 99.6 K to 96.9 K (-2.71 %) |
| Jan 29 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 50.42 | 2,500 | 126,050 | 99,607 | 102.1 K to 99.6 K (-2.45 %) |
| Jan 29 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Buy | M | 1.35 | 8,100 | 10,935 | 102,107 | 94 K to 102.1 K (+8.62 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 94,000 | |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 57.75 | 200 | 11,550 | 13,742 | 13.9 K to 13.7 K (-1.43 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 57.11 | 648 | 37,007 | 13,942 | 14.6 K to 13.9 K (-4.44 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 55.98 | 1,121 | 62,754 | 14,590 | 15.7 K to 14.6 K (-7.14 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 55.17 | 5,987 | 330,303 | 15,711 | 21.7 K to 15.7 K (-27.59 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 53.87 | 670 | 36,093 | 21,698 | 22.4 K to 21.7 K (-3.00 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 52.60 | 374 | 19,672 | 22,368 | 22.7 K to 22.4 K (-1.64 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 9,000 | 62,010 | 22,742 | 13.7 K to 22.7 K (+65.49 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 2,767 | 3,735 | 113,897 | |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 6,800 | 9,180 | 116,664 | |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 58.92 | 198 | 11,666 | 8,741 | 8.9 K to 8.7 K (-2.22 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 57.74 | 852 | 49,194 | 8,939 | 9.8 K to 8.9 K (-8.70 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 56.70 | 230 | 13,041 | 9,791 | 10 K to 9.8 K (-2.30 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.67 | 635 | 35,350 | 10,021 | 10.7 K to 10 K (-5.96 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 54.58 | 355 | 19,376 | 10,656 | 11 K to 10.7 K (-3.22 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 53.55 | 497 | 26,614 | 11,011 | 11.5 K to 11 K (-4.32 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 2,767 | 3,735 | 11,508 | 8.7 K to 11.5 K (+31.66 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 57.09 | 800 | 45,672 | 8,741 | 9.5 K to 8.7 K (-8.38 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.60 | 1,918 | 106,641 | 9,541 | 11.5 K to 9.5 K (-16.74 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.07 | 3,166 | 174,352 | 11,459 | 14.6 K to 11.5 K (-21.65 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 53.89 | 645 | 34,759 | 14,625 | 15.3 K to 14.6 K (-4.22 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 52.27 | 271 | 14,165 | 15,270 | 15.5 K to 15.3 K (-1.74 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 6,800 | 9,180 | 15,541 | 8.7 K to 15.5 K (+77.79 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 32,588 | |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 91,125 | |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 57.73 | 200 | 11,546 | 9,098 | 9.3 K to 9.1 K (-2.15 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 56.90 | 400 | 22,760 | 9,298 | 9.7 K to 9.3 K (-4.12 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 55.83 | 1,054 | 58,845 | 9,698 | 10.8 K to 9.7 K (-9.80 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 55.16 | 3,527 | 194,549 | 10,752 | 14.3 K to 10.8 K (-24.70 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 53.95 | 700 | 37,765 | 14,279 | 15 K to 14.3 K (-4.67 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 52.49 | 264 | 13,857 | 14,979 | 15.2 K to 15 K (-1.73 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 15,243 | 14.6 K to 15.2 K (+4.42 %) |
| Jan 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 14,598 | 9.1 K to 14.6 K (+60.45 %) |
| Jan 05 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | M | 0.38 | 9,000 | 3,420 | 69,000 | |
| Jan 05 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 62.44 | 110 | 6,868 | 7,688 | 7.8 K to 7.7 K (-1.41 %) |
| Jan 05 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 61.66 | 6,719 | 414,294 | 7,798 | 14.5 K to 7.8 K (-46.28 %) |
| Jan 05 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 61.09 | 2,171 | 132,626 | 14,517 | 16.7 K to 14.5 K (-13.01 %) |
| Jan 05 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Buy | M | 0.38 | 9,000 | 3,420 | 16,688 | 7.7 K to 16.7 K (+117.07 %) |